Publications by authors named "Mahul B Amin"

100Publications

Peyronie disease: a clinicopathologic study of 71 cases with emphasis on histopathologic patterns and prevalent metaplastic ossification.

Hum Pathol 2020 Oct 15;104:9-17. Epub 2020 Jul 15.

Department of Pathology, VCU School of Medicine, Richmond, VA, 23298, USA; Division of Urology, Department of Surgery, VCU School of Medicine, Richmond, VA, 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2020.07.013DOI Listing
October 2020

Genital verruciform xanthoma: lessons from a contemporary multi-institutional series.

Histopathology 2020 Nov 15;77(5):841-846. Epub 2020 Sep 15.

Department of Pathology, VCU School of Medicine, Richmond, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14198DOI Listing
November 2020

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.

Arch Pathol Lab Med 2020 Jun 26. Epub 2020 Jun 26.

From the Departments of Pathology (Drs Epstein, DeMarzo, and Lotan), Urology (Dr Epstein), and Oncology (Dr Epstein), The Johns Hopkins Medical Institutions, Baltimore, Maryland; Department of Pathology and Laboratory Medicine and Urology, University of Tennessee Health Science, Memphis (Dr Amin); Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Fine); Department of Pathology, Fundacio Puigvert, Barcelona, Spain (Dr Algaba); Department of Pathology, University of Southern California, Los Angeles (Dr Aron); Department of Pathology, Faculty of Medicine, Koç University, İstanbul, Turkey (Dr Baydar); Department of Pathology, Champalimaud Centre for the Unknown, Lisbon, Portugal (Dr Beltran); Department of Pathology, McGill University Health Center, Montréal, QC, Canada (Dr Brimo); Department of Pathology, Mayo Clinic, Rochester, Minnesota (Drs Cheville and Jimenez); Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (Dr Colecchia); Department of Pathology, Hôpital Tenon, Sorbonne University, Paris, France (Dr Comperat); Pathology Department, Rede D'OR-Sao Luiz, Sao Paulo, SP, Brazil (Dr da Cunha); Douglass Hanly Moir Pathology, Sydney, Australia (Dr Delprado); Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee (Drs Giannico and Gordetsky); Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Guo); Department of Pathology, Oregon Health and Science University, Portland (Dr Hansel); Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts (Dr Hirsch); Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California (Dr Huang); Department of Pathology, Yale School of Medicine, New Haven, Connecticut (Dr Humphrey); Department of Pathology and Laboratory Medicine and Urology, Weill Cornell Medicine, New York, New York (Drs Khani and Robinson); Department of Pathology, Qingdao Municipal Hospital, Qingdao, Shandong, China (Dr Kong); Departments of Pathology and Laboratory Medicine and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida (Dr Kryvenko); Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan (Drs Kunju and Mehra); Perelman School of Medicine, University of Pennsylvania, Philadelphia (Dr Lal); Department of Pathology, CHUM, Université de Montréal, Montréal, QC, Canada (Dr Latour); Douglass Hanly Moir Pathology, Faculty of Medicine and Health Sciences Macquarie University, North Ryde, Australia (Dr Maclean); Department of Pathology, The University of Alabama at Birmingham, Birmingham (Drs Magi-Galluzzi and Netto); Department of Surgical Pathology, Tata Memorial Hospital, Parel, Mumbai, India (Dr Menon); Departments of Pathology and Laboratory Medicine and Urology, University of Rochester Medical Center, Rochester, New York (Dr Miyamoto); Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, United Hospitals, Ancona, Italy (Dr Montironi); Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio (Dr Nguyen); Department of Pathology, Emory University School of Medicine, Atlanta, Georgia (Dr Osunkoya); Department of Pathology, Ohio State University, Columbus (Drs Parwani and Zynger); Department for BioMedical Research, University of Bern, Bern, Switzerland (Dr Rubin); Department of Pathology, The University of Texas Southwestern Medical Center, Dallas (Dr Shah); Institute of Pathology, St Luke's Medical Center, Quezon City and Global City, Philippines (Dr So); Department of Pathology, The Jikei University School of Medicine, Tokyo, Japan (Dr Takahashi); Argos Laboratory, Federal University of Ceara, Fortaleza, Brazil (Dr Tavora); Department of Pathology, University of Washington School of Medicine, Seattle (Drs Tretiakova and True); Departments of Pathology and Laboratory Medicine and Urology, University of North Carolina, Chapel Hill (Dr Wobker); Department of Pathology, Northwestern University, Chicago, Illinois (Dr Yang); Department of Pathology, Tufts Medical Center, Boston, Massachusetts (Dr Zhou); and Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada (Dr Trpkov). Dr Kong is currently located at Kaiser Permanente Sacramento Medical Center, Sacramento, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2020-0015-RADOI Listing
June 2020

Convergence of Digital Pathology and Artificial Intelligence Tools in Anatomic Pathology Practice: Current Landscape and Future Directions.

Adv Anat Pathol 2020 07;27(4):221-226

Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000271DOI Listing
July 2020

CK20 versus AMACR and p53 immunostains in evaluation of Urothelial Carcinoma in Situ and Reactive Atypia.

Diagn Pathol 2020 May 26;15(1):61. Epub 2020 May 26.

Department of Pathology, Virginia Commonwealth University School of Medicine, PO Box 980662, Richmond, VA, 23298, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13000-020-00984-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251721PMC
May 2020

CD34 positive tubular basement membrane in testicular germ cell tumours: a potential staging pitfall.

Histopathology 2020 Aug 4;77(2):331-333. Epub 2020 Jul 4.

Department of Pathology, VCU School of Medicine, Richmond, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14131DOI Listing
August 2020

Urothelial Proliferation of Unknown Malignant Potential Involving the Bladder: Histopathologic Features and Risk of Progression in De Novo Cases and Cases With Prior Neoplasia.

Arch Pathol Lab Med 2019 Dec 11. Epub 2019 Dec 11.

From the Department of Pathology (Drs Lowenthal and Hansel) and the Department of Computer Science and Engineering (Dr Sahoo), University of California, San Diego, La Jolla; and the Department of Pathology, University of Tennessee Health Sciences Center, Memphis (Dr Amin). Dr Lowenthal is now with Kaiser Permanente, San Diego, California. Dr Hansel is now with the Department of Pathology, Oregon Health & Science University, Portland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2019-0005-OADOI Listing
December 2019

MiT family translocation renal cell carcinomas: A 15th anniversary update.

Histol Histopathol 2020 Feb 6;35(2):125-136. Epub 2019 Sep 6.

Department of Pathology, University of Tennessee Health Science Center, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14670/HH-18-159DOI Listing
February 2020

Amyloidosis of the bladder and association with urothelial carcinoma: report of 29 cases.

Hum Pathol 2019 11 16;93:48-53. Epub 2019 Aug 16.

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd Suite Room 8725, Los Angeles, CA 90048, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2019.08.011DOI Listing
November 2019

The American Joint Committee on Cancer turns 60.

Cancer 2019 08 23;125(15):2704-2705. Epub 2019 Apr 23.

American Joint Committee on Cancer, Chicago, Illinois.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32159
Publisher Site
http://dx.doi.org/10.1002/cncr.32159DOI Listing
August 2019

Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists.

Arch Pathol Lab Med 2019 05 13;143(5):550-564. Epub 2019 Mar 13.

From the Departments of Pathology (Drs Paner and Choy) and Surgery (Urology) (Dr Paner), University of Chicago, Chicago, Illinois; and the Departments of Pathology and Laboratory Medicine (Drs Gandhi and Amin) and Urology (Dr Amin), University of Tennessee Health Science Center, Memphis.

View Article

Download full-text PDF

Source
http://www.archivesofpathology.org/doi/10.5858/arpa.2018-033
Publisher Site
http://dx.doi.org/10.5858/arpa.2018-0334-RADOI Listing
May 2019

[Comparison of UICC and AJCC 8th edition TNM classifications in uropathology].

Ann Pathol 2019 Apr 30;39(2):158-166. Epub 2019 Jan 30.

Service d'anatomie et cytologie pathologiques, hôpital Tenon, HUEP, Sorbonne université, 4, rue de la Chine, 75020 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2018.12.005DOI Listing
April 2019

Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples.

Cancer Cytopathol 2018 12 19;126(12):992-1002. Epub 2018 Oct 19.

Department of Pathology, Virginia Commonwealth University (VCU) School of Medicine, Richmond, Virginia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.22071DOI Listing
December 2018

Reply to Vincenzo Di Nunno, Matteo Santoni, Alessia Cimadamore, Nicola Battelli, and Francesco Massari's Letter to the Editor re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, et al. Updates in the Eight Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560-9.

Eur Urol 2018 11 26;74(5):e120-e121. Epub 2018 Jul 26.

Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA; Department of Urology, University of Tennessee Health Science Center, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2018.07.007DOI Listing
November 2018

SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients.

Hum Pathol 2018 07 22;77:139-146. Epub 2018 Apr 22.

Institute of Pathology, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital of Erlangen, 91054 Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.04.004DOI Listing
July 2018

Morphological clues to the appropriate recognition of hereditary renal neoplasms.

Semin Diagn Pathol 2018 May 14;35(3):184-192. Epub 2018 Feb 14.

Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences, Memphis, USA; Department of Urology, University of Tennessee Health Sciences, Memphis, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S07402570183000
Publisher Site
http://dx.doi.org/10.1053/j.semdp.2018.01.005DOI Listing
May 2018

Trends in reporting histological subtyping of renal cell carcinoma: association with cancer center type.

Hum Pathol 2018 04 12;74:99-108. Epub 2018 Jan 12.

Intramural Research, American Cancer Society,Atlanta, GA 30303. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.01.010DOI Listing
April 2018

Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers.

Eur Urol 2018 04 9;73(4):560-569. Epub 2018 Jan 9.

Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA; Department of Urology, University of Tennessee Health Science Center, Memphis, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.12.018DOI Listing
April 2018

STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer.

Oncotarget 2017 Oct 12;8(49):85997-86010. Epub 2017 Sep 12.

Department of Biological Sciences, The Center for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, GA 30314, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689662PMC
October 2017

Penile warty mucoepidermoid carcinoma with features of stratified mucin-producing intra-epithelial lesion and invasive stratified mucin-producing carcinoma.

Histopathology 2018 Apr 14;72(5):867-873. Epub 2018 Jan 14.

Department of Pathology, Charles University, Medical Faculty and Charles University Hospital Plzen, Pilsen, Czech Republic.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13438DOI Listing
April 2018

The World Health Organisation 2016 classification of penile carcinomas: a review and update from the International Society of Urological Pathology expert-driven recommendations.

Histopathology 2018 May 9;72(6):893-904. Epub 2018 Feb 9.

Department of Cellular Pathology, St George's Healthcare NHS Foundation Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13429DOI Listing
May 2018

Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.

Hum Pathol 2017 09 15;67:134-145. Epub 2017 Jul 15.

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA; Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences, Memphis, TN, 38163, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.07.006DOI Listing
September 2017

Pericytic tumors of the kidney-a clinicopathologic analysis of 17 cases.

Hum Pathol 2017 06 21;64:106-117. Epub 2017 Apr 21.

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA; Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Memphis, TN, 38163, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2017.04.005DOI Listing
June 2017

S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers.

Adv Anat Pathol 2017 May;24(3):151-160

*Department of Laboratory and Transfusion Services, Rajiv Gandhi Cancer Research Institute, Delhi, India †Department of Pathological Anatomy, San Carlos Hospital Clinic/Complutense University, Madrid, Spain §Department of Diagnostics and Public Health, University of Verona, Verona, Italy ‡Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA ∥Departments of Pathology and Urology, VCU School of Medicine, Richmond, VA ¶Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000150DOI Listing
May 2017

Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances.

Adv Anat Pathol 2017 May;24(3):113-127

*Department of Pathology and Surgery, Section of Urology, University of Chicago, Chicago, IL ‡Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN †Section of Pathological Anatomy, School of Medicine, Polytechnic University of the Marche Region, Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000152DOI Listing
May 2017

Reporting and Staging of Testicular Germ Cell Tumors: The International Society of Urological Pathology (ISUP) Testicular Cancer Consultation Conference Recommendations.

Am J Surg Pathol 2017 Jun;41(6):e22-e32

*Nuffield Department of Surgical Sciences, University of Oxford, Oxford ††Department of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom †Department of Pathology and Laboratory Medicine, Calgary Laboratory Services and University of Calgary, Calgary, AB ‡Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada §Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Centre, Los Angeles, CA #Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN **Department of Pathology, Memorial Sloan Kettering Cancer Centre, New York, NY ‡‡Department of Pathology, John Hopkins Hospital, Baltimore, MD ∥Department of Pathology, Hopital Tenon, Assistance Publique - Hopitaux de Paris, Université Pierre et Marie Curie, Paris VI, Paris, France ¶Department of Pathology and Cytology, Karolinska Hospital, Stockholm, Sweden §§Members of the ISUP Testicular Tumor Panel: Brett Delahunt, Cristina Magi-Galluzzi, Ferran Algaba, Esther Oliva, Rodolfo Montironi, Robert H Young, Muhammad T Idrees, Sean R Williamson, Ming Zhou, Peter A Humphrey, Antonio Lopez-Beltran, and Joanna Perry-Keene.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000844DOI Listing
June 2017

Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

CA Cancer J Clin 2017 05 21;67(3):245-253. Epub 2017 Feb 21.

Chief of Urologic Oncology, Department of Urology, University of Washington, and Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21391DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6375094PMC
May 2017

Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.

Am J Surg Pathol 2017 Apr;41(4):e1-e7

*Department of Pathology, Urology, and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD †Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN ‡Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY §Department of Pathology, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000820DOI Listing
April 2017

Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.

Am J Surg Pathol 2016 11;40(11):1457-1472

*Departments of Pathology and Urology, VCU Health, Richmond, VA †Calgary Laboratory Services and University of Calgary, Calgary, AB ¶¶Department of Pathology, McGill University, Montreal, QC, Canada ‡Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY §Department of Pathology, University of Michigan ∥∥∥∥Michigan Center for Translational Pathology, Department of Urology, Comprehensive Cancer Center, University of Michigan, Ann Arbor **Department of Pathology, William Beaumont Health System, Royal Oak ∥∥∥Department of Pathology, Henry Ford Health System, Detroit, MI ∥Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA ¶Institute of Pathology, Kantonsspital St. Gallen, Switzerland #Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy ††Department of Pathology, Charles University and University Hospital, Plzen, Czech Republic ‡‡Department of Pathology and Uro-oncology Disease Management Group, Tata Memorial Hospital, Mumbai, India §§Department of Anatomic Pathology, A.C. Camargo Cancer Center, Sao Paulo, Brazil ∥∥Department of Pathology, Azienda Ospedaliera Universitaria Senese, Siena, Italy ##Cancer Diagnosis and Pathology Group, Kolling Institue of Medical Research, Royal North Shore Hospital ***Sydney Medical School, University of Sydney, Sydney ****Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia †††Department of Pathology, Emory University, Atlanta, GA ‡‡‡Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic, Cleveland, OH §§§Département d'Anatomie Pathologique, Hôpital Cochin, Université Paris Descartes, Paris, France ¶¶¶Division of Pathological Anatomy, University of Florence, Florence, Italy ###Department of Pathology, Loyola University, Maywood, IL ††††Institute of Pathology, Friedrich-Alexander University, University Hospital, Erlangen, Germany ‡‡‡‡Department of Pathology, Indiana University School of Medicine, Indianapolis, IN §§§§Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000719DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577927PMC
November 2016

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

J Clin Oncol 2016 07 4;34(20):2325-32. Epub 2016 Apr 4.

W. Robert Lee and Bridget F. Koontz, Duke University Medical Center, Durham, NC; James J. Dignam, University of Chicago, Chicago, IL; Mahul B. Amin and Howard M. Sandler, Cedars-Sinai Medical Center; Daniel Low, University of California, Los Angeles, Los Angeles; Samantha A. Seaward, Kaiser Permanente Northern California, Santa Clara, CA; Deborah W. Bruner, Emory University, Atlanta, GA; Gregory P. Swanson, Baylor Scott & White Healthcare Temple Clinic, Temple, TX; Amit B. Shah, York Cancer Center, York; James J. Dignam and Rebecca Paulus, NRG Oncology Statistics and Data Management Center, Philadelphia, PA; David P. D'Souza, London Regional Cancer Program, London, Ontario; Ian S. Dayes, McMaster University, Hamilton, Ontario; Sergio L. Faria, McGill University Health Center, Montreal, Quebec, Canada; Jeff M. Michalski, Washington University School of Medicine, St Louis, MO; William A. Hall, Medical College of Wisconsin, Milwaukee, WI; Paul L. Nguyen, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA; Thomas M. Pisansky, Mayo Clinic, Rochester, MN; and Yuhchyau Chen, University of Rochester, Rochester, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.0448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981980PMC
July 2016

Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin.

Adv Anat Pathol 2016 Mar;23(2):71-83

Departments of *Pathology †Surgery, Section of Urology, University of Chicago, Chicago, IL §Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA ‡Champalimaud Clinical Center, Lisbon, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000110DOI Listing
March 2016

American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine.

CA Cancer J Clin 2016 09 19;66(5):370-4. Epub 2016 Jan 19.

Professor, Life Science, Arizona State University, Tempe, AZ; Professor, Laboratory Medicine and Pathology, Mayo Clinic School of Medicine, Rochester, MN; Chief Medical Officer, National Biomarker Development Alliance, Scottsdale, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3322/caac.21339DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955656PMC
September 2016

Emerging Entities in Renal Neoplasia.

Surg Pathol Clin 2015 Dec;8(4):623-56

Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2015.08.004DOI Listing
December 2015

The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.

Am J Surg Pathol 2016 Feb;40(2):244-52

*Departments of Pathology, Urology, and Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD†Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden‡Department of Pathology & Laboratory Medicine, Cedars-Sinai, Los Angeles, CA§Department of Pathology & Molecular Medicine, Wellington School of Medicine & Health Sciences, University of Otago-Wellington, Wellington South, New Zealand∥Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada¶Department of Pathology, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000530DOI Listing
February 2016

Machine learning approaches to analyze histological images of tissues from radical prostatectomies.

Comput Med Imaging Graph 2015 Dec 20;46 Pt 2:197-208. Epub 2015 Aug 20.

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA; Department of Biomedical Sciences Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062020PMC
http://dx.doi.org/10.1016/j.compmedimag.2015.08.002DOI Listing
December 2015

Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.

Am J Surg Pathol 2015 Jul;39(7):873-88

*Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA ‡Department of Pathology, Brigham and Women's Hospital, Boston, MA ¶Department of Pathology, MD Anderson Cancer Center ††Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX #Department of Pathology, Loyola University Hospital, Chicago, IL †Department of Pathology, Charles University in Prague, Pilsen, Czech Republic §Department of Pathology, l'Hotel-Dieu, place du Parvis, Paris ∥Department of Pathology, Hôpital Foch, Suresnes, France **Department of Pathology, Polytechnic University of the Marche Region, Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000446DOI Listing
July 2015

Clear cell papillary renal cell carcinoma: a review.

Int J Clin Exp Pathol 2014 15;7(11):7312-8. Epub 2014 Oct 15.

Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270541PMC
April 2017

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

J Clin Oncol 2015 Feb 22;33(4):332-9. Epub 2014 Dec 22.

Thomas M. Pisansky, Mayo Clinic, Rochester, MN; Daniel Hunt and James J. Dignam, Radiation Therapy Oncology Group Statistical Center; Leonard G. Gomella, Thomas Jefferson University, Philadelphia, PA; Mahul B. Amin and Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles; Daniel M. Chinn, John Muir Medical Center-Concord Campus, Concord; Seth A. Rosenthal, Sutter Medical Group, Sacramento, CA; Michael J. Seider, Akron City Hospital, Akron, OH; Elizabeth M. Gore, Zablocki Veterans Administration Medical Center-Wood, Milwaukee, WI; Marvin Z. Rotman, Brooklyn Minority-Based Community Clinical Oncology Program, State University of New York Downstate, Brooklyn, NY; William U. Shipley, Massachusetts General Hospital, Boston, MA; James J. Dignam, University of Chicago, Chicago, IL; Alexander G. Balogh, Tom Baker Cancer Centre, Calgary, Alberta; Marie Duclos, McGill University, Montreal, Quebec; Glenn S. Bauman, London Regional Cancer Program, London; and Himanshu R. Lukka, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/12/22/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.0662
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.0662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302214PMC
February 2015

Active surveillance for prostate cancer: the role of the pathologist.

Pathology 2015 Jan;47(1):1-3

1Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand 2Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA 3Department of Oncology and Pathology, Karolinska University Hospital, Solna, Stockholm, Sweden 4Aquesta Pathology and University of Queensland, Brisbane, Qld, Australia 5Trillium Health Partners, Mississauga and McMaster University, Hamilton, ON, Canada 6Department of Pathology, Yale University School of Medicine, New Haven, CT, USA 7Institute for Precision Medicine and the Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell, University and New York-Presbyterian Hospital, New York, NY, USA 8Department of Pathology, Urology and Oncology, Johns Hopkins School of Medicine, Baltimore, MA, USA 9Department of Urology, University of Washington, Seattle, WA, USA 10Department of Surgery, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand 11Division of Urology, Sunnybrook Health Sciences, Centre, University of Toronto, Toronto, ON, Canada 12Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA 13Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA 14Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA, USA 15Section of Pathological Anatomy, Department of Biomedical Sciences and Public Health, Polytechnic University of the Marche Region (Ancona), Ancona, Italy 16University Health Network, University of Toronto, Toronto, Ontario, Canada 17Pathology and Laboratory Medicine Institute, Cleveland Clinic Foundation, Cleveland, OH, USA 18Department of Cellular Pathology, The Royal London Hospital, London, UK 19Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA 20Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA 2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000186DOI Listing
January 2015

The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.

Arch Pathol Lab Med 2014 Oct 5;138(10):1387-405. Epub 2014 Aug 5.

From the Departments of Pathology and Laboratory Medicine (Drs Amin and Knudsen), Radiation Oncology (Dr Sandler), Urology (Dr Holden), and Biomedical Sciences (Dr Knudsen), Cedars-Sinai Medical Center, Los Angeles, California; the Departments of Urology (Drs Lin and Gore) and Pathology (Dr True), University of Washington, Seattle; Trillium Health Partners, Mississauga, Ontario, Canada, and McMaster University, Hamilton, Ontario, Canada (Dr Srigley); Aquesta Pathology, Toowong, Queensland, Australia, and the University of Queensland, Brisbane (Dr Samaratunga); the Department of Oncology and Pathology, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden (Dr Egevad); the Institute for Precision Medicine and the Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, Ithaca, New York, and New York-Presbyterian Hospital, New York (Dr Rubin); the Departments of Surgery (Dr Nacey) and Pathology and Molecular Medicine (Dr Delahunt), Wellington School of Medicine and Health Sciences, University of Otago, Newtown, Wellington, New Zealand; the James Buchanan Brady Urological Institute (Dr Carter) and the Departments of Pathology (Dr Epstein), Urology (Dr Epstein), and Oncology (Dr Epstein), Johns Hopkins School of Medicine, Baltimore, Maryland; Division of Urology, the Sunnybrook Health Sciences Centre (Dr Klotz) and the University Health Network (Dr Evans), University of Toronto, Toronto, Ontario, Canada; the Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston (Dr Zietman); the Section of Pathological Anatomy, Department of Biomedical Sciences and Public Health, Polytechnic University of the Marche Region, Ancona, Italy (Dr Montironi); the Department of Pathology, Yale University School of Medicine, New Haven, Connecticut (Dr Humphrey); the Pathology and Laboratory Medicine Institute, Cleveland Clinic Foundation, Cleveland, Ohio (Dr McKenney); the Department of Cell

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0219-SADOI Listing
October 2014

Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.

Mod Pathol 2015 Jan 18;28(1):80-94. Epub 2014 Jul 18.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2014.86DOI Listing
January 2015

Best practices recommendations in the application of immunohistochemistry in the bladder lesions: report from the International Society of Urologic Pathology consensus conference.

Am J Surg Pathol 2014 Aug;38(8):e20-34

*Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA §Department of Pathology, Indiana University School of Medicine, Indianapolis, IN †Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB, Canada ‡Unit of Anatomic Pathology, Department of Surgery Universidad de Cordoba, Cordoba, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000240DOI Listing
August 2014

Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification.

Am J Surg Pathol 2014 Aug;38(8):1033-45

*Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA †Department of Pathology, Indiana University School of Medicine, Indianapolis, IN ∥Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX ¶James Homer Wright Pathology Laboratories, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA ‡Department of Pathology, The University of Hong Kong, Pokfulam §Department of Clinical Pathology, Tuen Mun Hospital, Tuen Mun, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000250DOI Listing
August 2014

Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference.

Am J Surg Pathol 2014 Aug;38(8):1017-22

*Department of Pathology & Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA †Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD ‡Department of Pathology, Indiana University School of Medicine, Indianapolis, IN §Department of Pathology & Immunology, Washington University School of Medicine, St Louis, MO ††Department of Pathology, New York University Medical Center ¶¶Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY ∥Department of Pathology-Oncology, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden ¶Section of Pathological Anatomy, Polytechnic University of the Marche Region School of Medicine, United Hospitals, Ancona, Italy #Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB ∥∥Trillium Health Partners, Mississauga and McMaster University, Hamilton, ON, Canada **Unit of Anatomic Pathology, Department of Surgery Universidad de Cordoba, Cordoba, Spain ‡‡Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, Wellington, New Zealand §§Department of Cellular Pathology, Centre for Molecular Oncology, Queen Mary University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000254DOI Listing
August 2014

Evaluation of contemporary prostate and urothelial lineage biomarkers in a consecutive cohort of poorly differentiated bladder neck carcinomas.

Am J Clin Pathol 2014 Aug;142(2):173-83

From the Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPK1OV6IMNPFGLDOI Listing
August 2014

Melanotic Sertoli cell tumor.

Am J Surg Pathol 2014 Sep;38(9):1305-6

Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000281DOI Listing
September 2014

Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity.

Am J Surg Pathol 2014 Jul;38(7):871-4

*Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA ‡Department of Pathology, Johns Hopkins Hospital, Baltimore, MD ¶Department of Pathology, Indiana University School of Medicine, Indianapolis, IN **Department of Pathology, Brigham and Women's Hospital, Boston, MA ††Division of Anatomic Pathology, Mayo Clinic, Rochester, MN ‡‡Department of Pathology, University of Michigan, Ann Arbor, MI ∥∥Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH ***Department of Pathology, University of Chicago, Chicago, IL †††Department of Pathology, MD Anderson Cancer Center, Houston, TX §§§Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY †Institute of Pathology, Universitätsklinikum Erlangen, Erlangen, Germany §Department of Pathology, Groupe Hospitalier La Pitie-Salpêtrière, Université Pierre et Marie Curie, Paris, France ∥Department of Pathology, Wellington School of Medicine and Health Sciences, University of Otago, Otago, New Zealand #Department of Pathology, Faculty of Medicine in Plzeň, Charles University in Prague, Prague, Czech Republic §§Department of Pathology and Diagnostics, University of Verona, Verona ##Section of Pathological Anatomy, Polytechnic University of Medicine, United Hospitals, Ancona, Italy ¶¶Department of Pathology, University of Hospital Zurich, Zurich, Switzerland ‡‡‡Department Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000222DOI Listing
July 2014

Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Am J Surg Pathol 2014 Jun;38(6):756-67

Departments of *Pathology †Urology ‡Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD §Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA Departments of ∥Medicine ¶Pathology and Laboratory Medicine #Institute for Precision Medicine, Weill Medical College of Cornell University and New York-Presbyterian Hospital **Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY ††Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112087PMC
June 2014

t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases.

Am J Surg Pathol 2014 May;38(5):604-14

Departments of *Pathology †Urology ‡Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD §Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY ∥Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370182PMC
May 2014

Haemangiomas in kidneys with end-stage renal disease: a novel clinicopathological association.

Histopathology 2014 Sep 29;65(3):309-18. Epub 2014 May 29.

Department of Pathology, University of Miami, Miami, FL, USA; Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD, USA; Department of Pathology, Henry Ford Hospital, Detroit, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12394DOI Listing
September 2014

Uroplakin II outperforms uroplakin III in diagnostically challenging settings.

Histopathology 2014 Jul 25;65(1):132-8. Epub 2014 Feb 25.

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12360DOI Listing
July 2014

Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists.

Am J Surg Pathol 2014 Feb;38(2):167-75

*Department of Pathology, University of Chicago, Chicago, IL †Department of Biostatistics and Bioinformatics, Rollins School of Public Health §§Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA ‡Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA §Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ∥Department of Pathology, Johns Hopkins Hospital, Baltimore, MD ¶Department of Pathology, University of California, San Diego, CA #Division of Anatomic Pathology, Mayo Clinic, Rochester, MN **Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH ‡‡Department of Pathology, Massachusetts General Hospital, Boston, MA ∥∥Department of Pathology, MD Anderson Cancer Center ##Department of Pathology, Methodist Hospital, Houston, TX ¶¶Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York ‡‡‡Department of Pathology, University of Rochester Medical Center, Rochester, NY ††Section of Pathological Anatomy, Polytechnic University of the Marche Region, Ancona, Italy ***Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada †††Department of Pathology, Nagoya Daini Red Cross Hospital, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ajsp/2014/02000/Influence_of_Hi
Web Search
http://dx.doi.org/10.1097/PAS.0000000000000096DOI Listing
February 2014

Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations.

Am J Surg Pathol 2013 Oct;37(10):1505-17

*Department of Pathology and Laboratory Medicine, University of Calgary and Calgary Laboratory Services, Calgary, AB ∥∥Department of Laboratory Medicine, Credit Valley Hospital, Mississauga ¶¶Department of Pathology and Molecular Medicine, McMaster University, Toronto, ON, Canada †Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN ‡Nephropath, Little Rock, AR §Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA **Department of Pathology, MD Anderson Cancer Center Houston, Houston, TX ∥School of Medical Sciences, State University of Campinas (Unicamp), Campinas, Brazil ¶Department of Pathology and Surgery, University of Cordoba Medical School, Cordoba, Spain #Aquesta Pathology, University of Queensland, Brisbane, Qld, Australia ††Department of Pathology and Molecular Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand ‡‡Department of Oncology and Pathology, Karolinska University Hospital, Solna, Stockholm, Sweden §§Section of Pathological Anatomy, Polytechnic University of Marche Region, United Hospitals Ancona, Ancona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e31829a85d0DOI Listing
October 2013

Urothelial eddies in papillary urothelial neoplasms: a distinct morphologic pattern with low risk for progression.

Int J Clin Exp Pathol 2013 15;6(8):1458-66. Epub 2013 Jul 15.

Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726961PMC
March 2014

ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology.

Eur Urol 2013 Jan 5;63(1):16-35. Epub 2012 Oct 5.

Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2012.09.063DOI Listing
January 2013

Smoothelin expression in the gastrointestinal tract: implication in colonic inertia.

Appl Immunohistochem Mol Morphol 2013 Oct;21(5):452-9

*Department of Pathology and Laboratory Medicine ∥Gastrointestinal Motility Program, Division of Gastroenterology, Cedars-Sinai Medical Center ¶Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA †Department of Anatomical Pathology, Cleveland Clinic Foundation, Cleveland, OH ‡Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY §Department of Pathology, University of Chicago Hospitals, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e31827387c9DOI Listing
October 2013

Necrotizing palisading granuloma of the bladder in an otherwise healthy young man.

Arch Pathol Lab Med 2012 Jun;136(6):679-80

Division of Histology and Molecular Diagnostics, University Hospital Careggi, Viale G B Morgagni 85, Florence, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2011-0401-CRDOI Listing
June 2012

Frequency and determinants of disagreement and error in gleason scores: a population-based study of prostate cancer.

Prostate 2012 Sep 6;72(13):1389-98. Epub 2012 Jan 6.

Department of Epidemiology, Emory University Rollins School of Public Health, 1518 Clifton Road, NE Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22484DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339279PMC
September 2012

Non-epithelial neoplasms of the prostate.

Histopathology 2012 Jan;60(1):166-86

Department of Pathology, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1365-2559.2011.04020.x
Publisher Site
http://dx.doi.org/10.1111/j.1365-2559.2011.04020.xDOI Listing
January 2012

Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney.

Mod Pathol 2012 Jan 26;25(1):100-11. Epub 2011 Aug 26.

Department of Pathology and Diagnostics, University of Verona, Verona, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2011.136DOI Listing
January 2012